Sami Labs Limited

Other

Sami-sabinsa Group Limited

Majeed, Muhammed

Beena Bhat

Muhammed Majeed

Kalyanam Nagabhushanam

Anjali Pandey

Sarang Bani

Priti Vaidyanathan

Douglas Kalman

Suresh Karri

Natarajan Sankaran

Anurag Pande

Geetha Kanhangad-Gangadharan

Nagabhushanam Kalyanam

Garima Agarwal

Susmitha Anand-Tathapudi

Pritee Paliwal

Geetha Kanhangad Gangadharan

Susmitha Tathapudi Anand

The present invention relates to a process for the isolation of bioactive components from spent turmeric () and compositions comprising said bioactive components. Further, the present invention also elucidates the potent anti-inflammatory activity of said bioactive compositions and therapeutic applications thereof in rheumatoid arthritis.

Isolates from spent turmeric for the management of rheumatoid arthritis

Disclosed are compositions enriched with thymohydroquinone, further comprising of thymoquinone, hederagenin and/or &#x3b1;-hederin formulated by blending the active molecules isolated from the seeds of. Also disclosed are novel processes for the isolation of bioactive components thymohydroquinone, thymoquinone from the seeds of. A process for the isolation &#x3b1;-hederin and hederagenin from the spent material ofis also disclosed herein.

Compositions containing thymohydroquinone and their method of preparation

Disclosed are the compositions comprising bioactive components Oroxylin A, Baicalein, Chrysin, and their glucuronides Oroxylin A-7-glucuronide, Baicalein-7-glucuronide and Chrysin-7-glucuronide, isolated from the bark of, and the process of isolating the said bioactives.

Composition containing Oroxylin A and method of extraction thereof

Disclosed is a novel process for the isolation of bioactive compounds from. More specifically, the invention discloses a process for isolation and enrichment of bioactive compounds Arjunic acid, Arjunolic acid, Arjungenin, Arjunetin, Arjunoglucoside-I, Arjunoglucoside-II, and Catechin from the bark of. The invention also discloses a composition standardized to contain 3% arjunoglucosides isolated from the bark of

Process for the preparation of standardized composition of arjunoglucoside from the bark of

Disclosed are methods of managing hypercholesterolemia using a composition of matter comprising the ethyl acetate fraction of the extract ofrhizomes standardized to contain 5% of total stilbenes.

Composition comprising scirpusin A and scirpusin B and anti-obesity potential thereof

Disclosed are methods of managing obesity and hypercholesterolemia using a composition of matter comprising the ethyl acetate fraction of the extract ofrhizomes standardized to contain 5% of total stilbenes.

Disclosed is a composition comprising scirpusin A and scirpusin B and anti-obesity potential thereof. Also disclosed are methods of inhibiting adipogenesis using a composition comprising scirpusin A and scirpusin B. The present invention also disclosed methods of therapeutically managing obesity in mammals using a composition comprising scirpusin A and scirpusin B. Still further, the present invention also relates to a method of obtaining compositions comprising A. scirpusin A and scirpusin B and B. piceatannol and its dimers scirpusin A and scirpusin B through bioactivity guided fractionation of the rhizomes of

Composition comprising scirpusin A and scirpusin B and anti-adipogenesis/anti-obesity potential thereof

The present invention relates to preservation of cosmetic formulations. More specifically, the present invention relates to a preservative composition for cosmetic formulations comprising thymol, monolaurin and magnolol obtained from supercritical fluid extracts of

Preservative system for cosmetic formulations&#x2014;compositions and methods thereof

Disclosed are novel protective compositions for dermal papilla cells. In an embodiment the protective compositions of the present invention comprise 0.25% w/w or above of compositions comprising at least 10% w/w and above of 1-O-galloyl-&#x3b2;-D-glucose (&#x3b2;-glucogallin). In an embodiment, the said protective composition additionally comprises 50% to greater than 50% gallates including mucic acid 1,4-lactone 5-O-gallate, mucic acid 2-O-gallate, mucic acid 6-Methyl ester 2-O-gallate, mucic acid 1-Methyl ester 2-O-gallate and ellagic acid. In another embodiment the invention also encompasses synergistic protective compositions comprising the said protective compositions and 0.5% concentrate of liquid endosperm of, for dermal papilla directed towards helping the dermal papilla cells to form sufficient numbers and to retain a healthy morphology conducive for hair growth.

Growing community of inventors

Bengaluru, India

Beena Bhat